Mood and the menopause

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 1, 1999, Pages 1-4

  Klein, Pavel ^a   Versi, Eboo ^a   Herzog, Andrew ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; PROGESTERONE; SEX HORMONE;

AFFECTIVE NEUROSIS; ANXIETY NEUROSIS; BRAIN FUNCTION; DEPRESSION; FEMALE; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; MOOD; PRIORITY JOURNAL; SHORT SURVEY;

AFFECT; BRAIN; FEMALE; GONADAL STEROID HORMONES; HUMANS; MENOPAUSE;

EID: 0032952189     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08077.x     Document Type: Note

References (47)

1. Jackson SW. Melancholia and depression: from Hippocratic times to modern times. New Haven: Yale University Press, 1986.
2. Hunter MS. Depression and the menopause. EMJ 1996; 313: 1043–1044.
3. Pearce J, Hawton K, Blake F. Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. Br J Psych 1995; 167: 163–173.
4. Gitlin MJ, Pasnau RO. Psychiatric syndromes linked to reproductive function in women: a review of current knowledge. Am J Psych 1989; 146: 1413–1422.
5. Nicol Smith L. Causality, menopause and depression: a critical review of the literature. BMJ 1996; 313: 1129–1132.
6. Holte A. Influences of natural menopause on health complaints; a prospective study of healthy Norwegian women. Maturitas 1992; 14: 127–141.
7. Hunter MS. Somatic experience of the menopause: a prospective study. Psychosom Med 1990; 52: 357–3672.
8. McKinlay JB, McKinlay SM, Brambilla DJ. The relative contributions of endocrine changes and social circumstances to depression in mid-aged women. J Health Soc0 Behav 1987; 28: 345–363.
9. Ballinger CB, Browning MCK, Smith AHW. Hormone profiles and psychological symptoms in perimenopausal women. Muturitas 1987; 9: 235–251.
10. Avis NE, Brambilla D, McKinlay SM, Vass KA. A longitudinal analysis of the association between menopause and depression. Ann Epdemiol 1994; 4: 214–220.
11. Kaufen PA, Gilbert P, Tate R. The Manitoba project: a re-examination of the link between menopause and depression. Muturitas 1992; 14: 143–156.
12. Hunter M. The South-East England longitudinal study of the climacteric and postmenopause. Maturitas 1992; 14: 117–126.
13. Buckler HM, Evans A, Mamlora H et al. Gonadotropin, steroid and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory ‘rebound’ cycles. J Clin Endocrinol Metab 1991; 72: 116–124.
14. Halbreich U. Role of estrogen in postmenopausal depression. Neurology 1997; 48 (Suppl7): S16–S20.
15. Landgren BM, Unden AL, Diczfalusy E. Hormonal profiles of 68 normally menstruating women. Acta Endocrinol 1980; 94: 89–98.
16. Simerly RB, Chang C, Muramatsu M et al. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: and in situ hybridization study. J Com Neurol 1990; 294.6–95.
17. Paul SM, Purdy RH. Neuroactive steroids. FASEE 1992; 6: 2311–2322.
18. Woolley CS, McEwen BS. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 1993; 336: 293–306.
19. Smith SS. Estrogen administration increases neuronal responses to excitatory amino acids as a long term effect. Brain Res 1989; 503: 354–357.
20. Wong M, Moss RL. Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CAI neurons. J Neurosci 1992; 12: 3217–3225.
21. Pecins- Thompson M, Brown NA, Kohama SG et al. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci 1996; 16: 7021–7029.
22. Biegnon A, Reches A, Snyder L, McEwen BS. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci 1983; 32: 2015–2021.
23. Luine VN, Khylchevskaya R, McEwen BS. Effect of gonadal steroids on activities of monoamine oxidase and choline acetyl transferase in rat brain. Brain Res 1975; 86: 293–306.
24. Briggs M, Briggs M. The relationship between monoamine oxidase activity and sex hormone concentrations in human blood plasma. J Reprod Fertil 1972; 29: 447–450.
25. Fishman J. Biological action of catechol estrogens. J Endocrinol 1981; 89: 59–65.
26. Morrell JI, McGianty JF, Pfaff DW. A subset of b-endorphin-or dynorphin-containing neurons in the medial basal hypothalamus accumulates estradiol. Neuroendocrinol 1986; 41: 417–426.
27. Barden N, Merand Y, Ruleau D et al. Changes in the b-endorphin content of discrete hypothalamic nuclei during the estrous cycle of therat. Bruin Res 1981; 204: 441–445.
28. Majewska MD, Harrison NL, Schwartz RD et al. Steroid hormone metabolites and barbiturate-like modulators of the GABA receptor. Science 1986; 232: 1004–1007.
29. Bernardi M, Vergoni AV, Sandrini M et al. Influence of ovariectomy, estradiol and progesterone on the behavior of mice in an experimental model of depression. Physiol Behav 1989; 45: 1067–1068.
30. Selye H. The anesthetic effect of steroid hormones. Proc Soc Exp Biol Med 1941; 46: 116–121.
31. Crowley JN, Glowa JR, Majewska MD, Paul SM. Anxiolytic activity of endogenous adrenal steroid. Er Res 1986; 398: 382–385.
32. Bitran D, Purdy RH, Kellogg CK. Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function. Pharmacol Biochem Behav 1993; 45: 423–428.
33. Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scandnav 1976; 54: 321–347.
34. Cawood EHH, Bancroft J. Steroid hormone, the menopause, sexuality and well-being of women. Psycho/ Med 1996; 26: 925–936.
35. De Lignieres B, Vincens M. Differential effects of exogenous oestradiol and progesterone on mood in different post-menopausal women: individual dose/effect relationship. Maturitas 1982; 4: 67–72.
36. Klaiber EL, Broverman DM. Vogel W et al. Estrogen therapy for severe persistent depression in women. Arch Gun Psych 1979; 36: 550–554.
37. Oppenheim G. A case of rapid mood cycling with estrogen: Implication for therapy. J Clin Psych 1984; 45: 34–35.
38. Shapira B. Oppenheim G. Zohar J et al. Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biol Psych 1985; 20: 570–583.
39. Montgomery JC, Brincat M, Tapp A et al. Effect of estrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987; 1: 297–299.
40. Cheney DL, Uzunov D, Costa E, Guidotti A. Gas chromatographicmass fragmentographic quantitation of 3 a-hydroxy-5 a-pregnan-20-one (allopregnanolone) and its precursors in blood and brain in adrenalectomised and castrated rats. J Neurosci 1995; 15: 4641–4650.
41. Geschwind MD, Galaburda AM. Cerebral lateralization. Arch Neurol 1985; 42: 428–459.
42. Howards R, Mason P, Tagavi E, Spears G. Brainstem auditory evoked responses (BAERs) during the menstrual cycle with and without premenstrual syndrome. Biol Psych 1992; 32: 682–690.
43. Herzog AG. Perimenopausal depression: possible role of anomalous brain substrates. Bruin Dyst 1989; 2: 146–154.
44. Hay AG, Bancroft J, Johnstone EC. Affective symptoms in women attending a menopause clinic. Br J Psych 1994; 164: 513–516.
45. Harlow BL, Cramer DW, Annis KM. Association of medically treated depression and age at natural menopause. Am J Epidemiol 1995: 141: 1170–1176.
46. Palinkas LA, Barrett-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 1992; 80: 30–36.
47. Barlow DH. Who understands the menopause Br J Obstet Gynaecol 1997; 107: 879–880.